专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-10443047-B2 优先权日:2014-05-01 标题 :Increasing cellular lipid production by increasing the activity of diacylglycerol acyltransferase and decreasing the activity of triacylglycerol lipase 发明人:TSAKRAKLIDES VASILIKI; BREVNOVA ELENA E 权利人:NOVOGY INC 摘要:Disclosed are methods and compositions for increasing the triacylglycerol content of a cell by up-regulating diacylglycerol acyltransferase and down-regulating triacylglycerol lipase. In some embodiments, a DGA1 protein is expressed and a native TGL3 gene is knocked out, thereby increasing the synthesis of triacylglycerol and decreasing its consumption, respectively.
专利号:US-2023364251-A1 优先权日:2020-08-06 标 题:Methods for the synthesis of protein-drug conjugates 发明人:BORCHARDT ALLEN; HUGHES ROBERT MICHAEL 权利人:CIDARA THERAPEUTICS INC 摘要:The present invention relates to intermediates and methods for synthesizing protein-drug conjugates that can be used for the treatment of diseases and related conditions.
专利号:US-9695214-B2 优先权日:2013-03-15 标 题 :Solid phase peptide synthesis processes and associated systems 发明人:SIMON MARK DAVID; PENTELUTE BRADLEY L; ADAMO ANDREA; HEIDER PATRICK LOUIS; JENSEN KLAVS F 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:Systems and processes for performing solid phase peptide synthesis are generally described. Solid phase peptide synthesis is a known process in which amino acid residues are added to peptides that have been immobilized on a solid support. In certain embodiments, the inventive systems and methods can be used to perform solid phase peptide synthesis quickly while maintaining high yields. Certain embodiments relate to processes and systems that may be used to heat, transport, and/or mix reagents in ways that reduce the amount of time required to perform solid phase peptide synthesis.
专利号:US-2007099915-A1 优先权日:2005-10-07 标题 :Inhibitors of the hiv integrase enzyme 发明人:DRESS KLAUS R; JOHNSON TED W; PLEWE MICHAEL B; TANIS STEVEN P; ZHU HUICHUN 权利人:PFIZER 摘要:The present invention is directed to compounds of formula (I), n nand pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIVâ€?) integrase enzyme.
专利号:US-2023365629-A1 优先权日:2018-06-15 标题:Synthesis of echinocandin antifungal agent
1: Spettel K, Galazka S, Kriz R, Camp I, Willinger B. Do Candida albicans Isolates with Borderline Resistant Micafungin MICs Always Harbor FKS1 Hot Spot Mutations? J Fungi (Basel). 2021 Jan 28;7(2):93. doi: 10.3390/jof7020093. 8(12):1867. doi: 10.3390/microorganisms8121867. 6: Mullins C, Beaulac K, Sylvia L. Reply: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment. Ann Pharmacother. 2020 Nov 15:1060028020973607. doi: 10.1177/1060028020973607. Epub ahead of print. 76(2):418-422. doi: 10.1093/jac/dkaa419. Japan Febrile Neutropenia Study Group. Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial. Int J Infect Dis. 2020 Nov;100:292-297. doi: 10.1016/j.ijid.2020.08.081. Epub 2020 Sep 3. 6(3):136. doi: 10.3390/jof6030136.
合成参考文献
参考文献:10.3109/13693780903471784 摘要:Choi JH, Kwon EY, Park CM, Choi SM, Lee DG, Yoo JH, Shin WS, Stevens DA. Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia. Med Mycol. 2010 Aug;48(5):704–9. doi: 10.3109/13693780903471784. 参考文献:10.1111/j.1442-200x.2009.02947.x 摘要:Okamoto T, Koh K, Takita J, Furuya A, Kato M, Ida K. Voriconazole–micafungin combination therapy for acute lymphoblastic leukemia. Pediatrics International. 2010 Jan 25;52(1):137–41. doi: 10.1111/j.1442-200x.2009.02947.x. 参考文献:10.3109/14767058.2011.604929 摘要:Manzoni P, Benjamin DK, Hope W, Rizzollo S, Sordo PD, Stronati M, Jacqz-Aigrain E, Castagnola E, Farina D. The management ofCandidainfections in preterm neonates and the role of micafungin. The Journal of Maternal-Fetal & Neonatal Medicine. 2011 Jul 12;24(sup2):24–7. doi: 10.3109/14767058.2011.604929. 参考文献:10.1089/jop.2011.0026 摘要:Mochizuki K, Suemori S, Udo K, Komori S, Ohkusu K, Yamada N, Ogura S. Intraocular Penetration of Micafungin in Patient with Candida albicans Endophthalmitis. Journal of Ocular Pharmacology and Therapeutics. 2011 Oct;27(5):531–3. doi: 10.1089/jop.2011.0026. 参考文献:10.1016/j.jbiosc.2011.06.002 摘要:Ueda S, Kinoshita M, Tanaka F, Tsuboi M, Shimizu S, Oohata N, Hino M, Yamada M, Isogai Y, Hashimoto S. Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907. Journal of Bioscience and Bioengineering. 2011 Oct;112(4):409–14. doi: 10.1016/j.jbiosc.2011.06.002.